WIINBERG ULF
SEC CIK 1187314 · EDGAR
BoughtSold
Most active insiders at INKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ryan Barbara | Dir | — | $46.6K |
| 2 | Holcomb John Bradley | Dir | — | — |
| 3 | Kadlec Robert Peter | Dir | — | — |
| 4 | Behner Peter | Dir | — | — |
| 5 | Buell Jennifer | CEO | — | — |
| 6 | Corvese Brian | Dir | — | — |
| 7 | WIINBERG ULF | Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 11:10 | 2026-09-01 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $10.95 | +1,279 | 23.9K | +6% | +$14.0K | |
| M | 2026-06-02 16:05 | 2026-03-02+ | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $11.59 | +2,416 | 22.6K | +12% | +$28.0K |
| 2025-12-03 | 2025-12-01 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $11.09 | +1,263 | 20.2K | +7% | +$14.0K | |
| 2025-09-03 | 2025-09-02 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $13.86 | +1,011 | 19.0K | +6% | +$14.0K | |
| 2025-06-04 | 2025-06-02 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $7.17 | +1,953 | 18.0K | +12% | +$14.0K | |
| 2025-03-05 | 2025-03-03 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $8.79 | +1,593 | 16.0K | +11% | +$14.0K | |
| 2024-12-03 | 2024-12-01 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $0.73 | +20.5K | 144.2K | +17% | +$14.9K | |
| 2024-09-05 | 2024-09-03 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $0.82 | +18.3K | 123.7K | +17% | +$15.0K | |
| 2024-06-05 | 2024-06-03 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $0.99 | +15.1K | 105.4K | +17% | +$14.9K | |
| 2024-03-05 | 2024-03-01 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $0.95 | +15.8K | 90.3K | +21% | +$15.0K | |
| 2023-12-05 | 2023-12-01 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $1.04 | +14.4K | 74.5K | +24% | +$15.0K | |
| 2023-11-17 | 2023-11-15 | AGEN | AGENUS INC | WIINBERG ULF | Dir | P - Purchase | $0.76 | +25.0K | 124.1K | +25% | +$19.0K | |
| 2023-09-06 | 2023-09-01 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $1.46 | +9,590 | 60.1K | +19% | +$14.0K | |
| 2023-06-02 | 2023-06-01 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $1.76 | +7,955 | 50.7K | +19% | +$14.0K | |
| 2023-03-03 | 2023-03-01 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $2.09 | +6,699 | 42.8K | +19% | +$14.0K | |
| 2022-12-05 | 2022-12-01 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $2.61 | +5,364 | 36.1K | +17% | +$14.0K | |
| 2022-09-19 | 2022-09-15 | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | A - Grant | $2.62 | +10.7K | 10.7K | New | +$28.0K | |
| M | 2022-07-21 | 2022-07-18+ | INKT | MiNK Therapeutics, Inc. | WIINBERG ULF | Dir | P - Purchase | $1.38 | +20.0K | 298.3K | +7% | +$27.6K |
Purchase Sale Sale after option exercise All abbreviations